NanoViricides, Inc. (NNVC) financial news, and detailed stock charts
NanoViricides, Inc. (NNVC/NNVC.OB) Stock Summary:
NanoViricides, Inc., a development stage nano-biopharmaceutical company, engages in the discovery, development, and commercialization of anti-viral therapeutics primarily in the United States. It has licenses in perpetuity to develop drugs for the treatment of human viral diseases, such as human immunodeficiency virus, Hepatitis B Virus, Hepatitis C Virus (HCV), Herpes Simplex Virus, Rabies, Influenza, and Asian Bird Flu Virus. The company’s products under development include FluCide-I for the treatment of common influenzas and avian influenza H5N1; AviFluCide-I against H5N1, the avian influenza strain; FluCide-HP against highly pathogenic avian influenza viruses; RabiCide-I, a nanoviricide ...www.nanoviricides.com
4 Employees
Founded in 2005
NANOVIRICIDES INC (NNVC:OTC Bulletin Board Market)
LAST $1.04 USD
CHANGE TODAY +0.021 2.06%
VOLUME 168.6K
As of 8:10 PM 01/28/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of NANOVIRICIDES INC (NNVC)
|
OPEN
$1.02
|
PREVIOUS CLOSE
$1.02
|
|
|
DAY HIGH
$1.05
|
DAY LOW
$1.02
|
|
|
52 WEEK HIGH
01/14/10 - $1.30
|
52 WEEK LOW
10/23/09 - $0.41
|
|
|
MARKET CAP
137.0M
|
AVERAGE VOLUME 10 D
386.7K
|
|
|
EPS TTM
$-0.04
|
SHARES OUTSTANDING
131.8M
|
|
|
NNVC Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for NANOVIRICIDES INC (NNVC)
NanoViricides, Inc. - Conference Presentation Call
01/11/2010
To outline the company's technology and the current drug programs
NanoViricides, Inc. - Conference Presentation Call
11/16/2009
NanoViricides, Inc. - Conference Presentation Calls
NanoViricides, Inc. announced delayed 10-Q filing
11/16/2009
On 11/16/2009, NanoViricides, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
NanoViricides, Inc. financial resources
NNVC Competitors
| Company | Last | Change |
| BioCryst Pharmaceuticals Inc | $6.45 USD | -0.34 |
| InterMune Inc | $15.20 USD | +0.43 |
| Pharmasset Inc | $20.06 USD | +0.14 |
| Valeant Pharmaceuticals International | $33.36 USD | -0.47 |
| Vertex Link Corp | ¥21.00 JPY | 0.00 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | NNVC | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 26.8x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
NNVC |
||
|
NNVC transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About NanoViricides, Inc.
NanoViricides, Inc. to Present at the Nano and Green Tech 2009 Conference being held in conjunction with ChemShow 2009
2010-01-29 01:19:11
Quote: He will also provide a general overview of the Company’s majorproduct platform including the pan-influenza nanoviricide, FluCide(™),anti-HIV nanoviricide HIVCide™, the nanoviricide eye antiviral drugcandidate, and the Herpes cold sores and genital herpes drug candidate.http://www.miamiherald.com/news/florida/AP/v-print/story/1332029.html).AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for ...Read article
NanoViricides, Inc. to Present Anti-Influenza Drug Candidate FluCide Studies at the Influenza Congress 2009
2010-01-29 01:19:11
Quote: Thepanelists and participants include pharmaceutical and biotech decisionmakers and executives as well as government and regulatory agencyrepresentatives from a number of countries.This conference is designed to bring together key stakeholders from thepharmaceutical and biotech industries, as well as governmental scienceand regulatory segments to discuss appropriate responses to the evolvinginfluenza pandemic, according to the organizers.AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com...Read article
NanoViricides Presents FluCide Animal Study Data at Influenza Congress - Now Improved Substantially and Vastly Superior to Current Treatment
2010-01-29 01:19:10
Quote: The Company believes that the data wepresented at the Influenza Conference establish this pan-influenza drugcandidate as a leading anti-influenza drug in development.AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for viral therapy. The Company's novel nanoviricideâ„¢ classof drug candidates are designed to specifically attack enveloped virusparticles and to dismantle them. The Company is developing drugs...Read article
NanoViricides Announces That Its Major Shareholder Has Completed Programmed Sale
2010-01-29 01:19:09
Quote: (TheraCour®), amajor shareholder of the Company, completed its programmed sale ofshares of NanoViricides, Inc, in December, 2009. The programmed saleunder Securities and Exchange Commission Rule 10b5-1 was authorized andinitiated in February, 2009.TheraCour adopted the 10b5-1 plan to fund the improvement of itslaboratory facilities, the purchase of analytical equipment and thecosts of intellectual property (patent) protection. The expansion ofTheraCour’s laboratory facilities is intend...Read article
NanoViricides Invited to Present at the Biotech Showcase Conference in San Francisco
2010-01-29 01:19:09
Quote: Animal model studies of topical andgenital herpes are planned.“We are now well poised to further develop our drug candidates with theobjective of filing an IND application as soon as possible,†said Dr.Eugene Seymour, MD, MPH, CEO of the Company.Aboutthe Biotech Showcase™ (Innovation – Opportunity – Collaboration):www.biotechshowcase.com.AboutNanoViricides:NanoViricides,Inc. (www.nanoviricides.com)is a development stage company that is creating special purposenano...Read article
NanoViricides Files Quarterly Report
2010-01-29 01:19:09
Quote: Animal model studies of topical andgenital herpes are planned.“We are now well poised to further develop our drug candidates with theobjective of filing an IND application as soon as possible,†said Dr.Eugene Seymour, MD, MPH, CEO of the Company.AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for viral therapy. The Company's novel nanoviricide™ classof drug candidates are designed to specifi...Read article
NanoViricides Announces That Its Major Shareholder Has Completed Programmed Sale
2010-01-26 02:38:41
Quote: (TheraCour®), amajor shareholder of the Company, completed its programmed sale ofshares of NanoViricides, Inc, in December, 2009. The programmed saleunder Securities and Exchange Commission Rule 10b5-1 was authorized andinitiated in February, 2009.TheraCour adopted the 10b5-1 plan to fund the improvement of itslaboratory facilities, the purchase of analytical equipment and thecosts of intellectual property (patent) protection. The expansion ofTheraCour’s laboratory facilities is intend...Read article
NanoViricides Invited to Present at the Biotech Showcase Conference in San Francisco
2010-01-12 02:56:58
Quote: Animal model studies of topical andgenital herpes are planned.“We are now well poised to further develop our drug candidates with theobjective of filing an IND application as soon as possible,†said Dr.Eugene Seymour, MD, MPH, CEO of the Company.Aboutthe Biotech Showcase™ (Innovation – Opportunity – Collaboration):www.biotechshowcase.com.AboutNanoViricides:NanoViricides,Inc. (www.nanoviricides.com)is a development stage company that is creating special purposenano...Read article
NANOVIRICIDES, INC. Files SEC form 10-Q, Quarterly Report
2010-01-04 01:14:59
Quote: Forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause the actual results to
differ materially from any future results, performance or achievements expressed
or implied by such forward-looking statements.
Index
OUR CORPORATE HISTORY
NanoViricides, Inc. was incorporated under the laws of the State of Colorado on
July 25, 2000 as Edot-com.com, Inc. and was organized for the purpose of
conducting internet retail sales. On April 1, 2005, Edot-com...Read article
NANOVIRICIDES, INC. Files SEC form 8-K, Regulation FD Disclosure
2009-12-24 01:06:13
Quote: NANOVIRICIDES, INC.Request a Trial to NEW EDGAR Online Pro
Form
8-K for
NANOVIRICIDES, INC.
14-Aug-2009Regulation FD DisclosurePrivacy PolicyTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delays, or f...Read article
NanoViricides Files Quarterly Report
2009-12-01 04:05:54
Quote: Animal model studies of topical andgenital herpes are planned.“We are now well poised to further develop our drug candidates with theobjective of filing an IND application as soon as possible,†said Dr.Eugene Seymour, MD, MPH, CEO of the Company.AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for viral therapy. The Company's novel nanoviricide™ classof drug candidates are designed to specifi...Read article
NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies
2009-11-30 01:20:03
Quote: In particular, treatment with only 150mg/kgnanoviricides, as opposed to 4,200 mg/kg HAART drug cocktail (i.e. 28times greater dosage of HAART cocktail) resulted in viral load decreasethat was equal to or better than HAART, and double-positive CD4+/CD8+ Tcell counts that were equal to or better than HAART. In addition, thenanoviricides were superior to the HAART cocktail in all parametersevaluated.Significantly, the nanoviricide treatment was given only during thefirst week in this six-week anti-...Read article
Nanoviricides, Inc. CEO Dr. Eugene Seymour to Address the Livingston Healthcare and Life Science Stakeholders Summit
2009-11-30 01:20:02
Quote: Seymour.AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for viral therapy. The Company's novel nanoviricideâ„¢ classof drug candidates are designed to specifically attack enveloped virusparticles and to dismantle them. The Company is developing drugs againsta number of viral diseases including H1N1 swine flu, H5N1 bird flu,seasonal Influenza, HIV, oral and genital Herpes, viral diseases of theeye includin...Read article
NanoViricides Secures $4.3M in Financing
2009-11-30 01:20:01
Quote: The Company is filing a Form8-K disclosure with the SEC summarizing these activities on October 5,2009.“With sufficient working capital to last us through December 31, 2010,â€said Eugene Seymour, MD, MPH, CEO of the Company, “we are now ready toengage full steam with our high priority drug development activities.â€AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for viral therapy. The Com...Read article
NanoViricides, Inc. to Present Anti-Influenza Drug Candidate FluCide Studies at the Influenza Congress 2009
2009-11-30 01:20:00
Quote: Thepanelists and participants include pharmaceutical and biotech decisionmakers and executives as well as government and regulatory agencyrepresentatives from a number of countries.This conference is designed to bring together key stakeholders from thepharmaceutical and biotech industries, as well as governmental scienceand regulatory segments to discuss appropriate responses to the evolvinginfluenza pandemic, according to the organizers.AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com...Read article
NanoViricides Management Reports that the Company is Fiscally Sound and Its Drug Development Programs are Progressing Successfully
2009-11-30 01:20:00
Quote: Diwan, PhD, President of the Company, adding, “We now plan tofocus on filing our first IND application as early as possible.â€AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for viral therapy. The Company's novel nanoviricideâ„¢ classof drug candidates are designed to specifically attack enveloped virusparticles and to dismantle them. The Company is developing drugs againsta number of viral dis...Read article
NANOVIRICIDES, INC. Files SEC form 10-K, Annual Report
2009-11-30 01:20:00
Quote: Readers should carefully review the risk factors disclosed in this
Form 10-K and other documents filed by the Company with the SEC.
As used in this report, the terms "Company", "we", "our", "us" and "NNVC" refer
to Nanoviricides, Inc., a Nevada corporation.
PRELIMINARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report contains forward-looking statements within the meaning of the
federal securities laws. These include statements about...Read article
NanoViricides, Inc. to Present at the Nano and Green Tech 2009 Conference being held in conjunction with ChemShow 2009
2009-11-30 01:19:59
Quote: He will also provide a general overview of the Company’s majorproduct platform including the pan-influenza nanoviricide, FluCide(™),anti-HIV nanoviricide HIVCide™, the nanoviricide eye antiviral drugcandidate, and the Herpes cold sores and genital herpes drug candidate.http://www.miamiherald.com/news/florida/AP/v-print/story/1332029.html).AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for ...Read article
NanoViricides Presents FluCide Animal Study Data at Influenza Congress - Now Improved Substantially and Vastly Superior to Current Treatment
2009-11-30 01:19:58
Quote: The Company believes that the data wepresented at the Influenza Conference establish this pan-influenza drugcandidate as a leading anti-influenza drug in development.AboutNanoViricides:NanoViricides,Inc.www.nanoviricides.com)is a development stage company that is creating special purposenanomaterials for viral therapy. The Company's novel nanoviricideâ„¢ classof drug candidates are designed to specifically attack enveloped virusparticles and to dismantle them. The Company is developing drugs...Read article
Would you like to leave a comment about NanoViricides, Inc. NNVC/NNVC.OB
Find out what social network information about NanoViricides, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides NanoViricides, Inc.'s Stock there is more great Microcap and Stock Market information available at Realpennies.com